Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 313 to 324 of 324 entries
Sorted by: Best Match Show Resources per page
Overexpression of ZNT1 and NRAMP4 from the Ni Hyperaccumulator .

International journal of molecular sciences

Fasani E, DalCorso G, Zorzi G, Agrimonti C, Fragni R, Visioli G, Furini A.
PMID: 34769323
Int J Mol Sci. 2021 Nov 02;22(21). doi: 10.3390/ijms222111896.

Metalliferous soils are characterized by a high content of metal compounds that can hamper plant growth. The pseudometallophyte

Cite
Fasani E, DalCorso G, Zorzi G, et al. Overexpression of ZNT1 and NRAMP4 from the Ni Hyperaccumulator . Int J Mol Sci. 2021;22(21)doi: 10.3390/ijms222111896.
Fasani, E., DalCorso, G., Zorzi, G., Agrimonti, C., Fragni, R., Visioli, G., & Furini, A. (2021). Overexpression of ZNT1 and NRAMP4 from the Ni Hyperaccumulator . International journal of molecular sciences, 22(21), . https://doi.org/10.3390/ijms222111896
Fasani, Elisa, et al. "Overexpression of ZNT1 and NRAMP4 from the Ni Hyperaccumulator ." International journal of molecular sciences vol. 22,21 (2021). doi: https://doi.org/10.3390/ijms222111896
Fasani E, DalCorso G, Zorzi G, Agrimonti C, Fragni R, Visioli G, Furini A. Overexpression of ZNT1 and NRAMP4 from the Ni Hyperaccumulator . Int J Mol Sci. 2021 Nov 02;22(21). doi: 10.3390/ijms222111896. PMID: 34769323; PMCID: PMC8584810.
Copy Download .nbib Format: NLM
COVID-19 patients with abdominal aortic aneurysm may be at higher risk for sudden enlargement and rupture.

Journal of vascular surgery

Bozzani A, Arici V, Franciscone M, Ticozzelli G, Sterpetti AV, Ragni F.
PMID: 34774979
J Vasc Surg. 2022 Jan;75(1):387-388. doi: 10.1016/j.jvs.2021.10.003. Epub 2021 Nov 11.

No abstract available.

Cite
Bozzani A, Arici V, Franciscone M, et al. COVID-19 patients with abdominal aortic aneurysm may be at higher risk for sudden enlargement and rupture. J Vasc Surg. 2021;75(1):387-388doi: 10.1016/j.jvs.2021.10.003.
Bozzani, A., Arici, V., Franciscone, M., Ticozzelli, G., Sterpetti, A. V., & Ragni, F. (2022). COVID-19 patients with abdominal aortic aneurysm may be at higher risk for sudden enlargement and rupture. Journal of vascular surgery, 75(1), 387-388. https://doi.org/10.1016/j.jvs.2021.10.003
Bozzani, Antonio, et al. "COVID-19 patients with abdominal aortic aneurysm may be at higher risk for sudden enlargement and rupture." Journal of vascular surgery vol. 75,1 (2022): 387-388. doi: https://doi.org/10.1016/j.jvs.2021.10.003
Bozzani A, Arici V, Franciscone M, Ticozzelli G, Sterpetti AV, Ragni F. COVID-19 patients with abdominal aortic aneurysm may be at higher risk for sudden enlargement and rupture. J Vasc Surg. 2022 Jan;75(1):387-388. doi: 10.1016/j.jvs.2021.10.003. Epub 2021 Nov 11. PMID: 34774979; PMCID: PMC8582098.
Copy Download .nbib Format: NLM
Public health impact of the COVID-19 pandemic on the emergency healthcare system.

Journal of public health (Oxford, England)

Stirparo G, Oradini-Alacreu A, Migliori M, Villa GF, Botteri M, Fagoni N, Signorelli C, Sechi GM, Zoli A.
PMID: 34156071
J Public Health (Oxf). 2021 Jun 22; doi: 10.1093/pubmed/fdab212. Epub 2021 Jun 22.

BACKGROUND: The Lombardy region has been the Italian region most affected by the coronavirus disease 2019 (COVID-19) pandemic in 2020. The emergency healthcare system was under deep stress throughout the past year due to the admission of COVID-19 patients...

Cite
Stirparo G, Oradini-Alacreu A, Migliori M, et al. Public health impact of the COVID-19 pandemic on the emergency healthcare system. J Public Health (Oxf). 2021;doi: 10.1093/pubmed/fdab212.
Stirparo, G., Oradini-Alacreu, A., Migliori, M., Villa, G. F., Botteri, M., Fagoni, N., Signorelli, C., Sechi, G. M., & Zoli, A. (2021). Public health impact of the COVID-19 pandemic on the emergency healthcare system. Journal of public health (Oxford, England), . https://doi.org/10.1093/pubmed/fdab212
Stirparo, G, et al. "Public health impact of the COVID-19 pandemic on the emergency healthcare system." Journal of public health (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/pubmed/fdab212
Stirparo G, Oradini-Alacreu A, Migliori M, Villa GF, Botteri M, Fagoni N, Signorelli C, Sechi GM, Zoli A. Public health impact of the COVID-19 pandemic on the emergency healthcare system. J Public Health (Oxf). 2021 Jun 22; doi: 10.1093/pubmed/fdab212. Epub 2021 Jun 22. PMID: 34156071; PMCID: PMC8344573.
Copy Download .nbib Format: NLM
Tissue-Autonomous Phenylpropanoid Production Is Essential for Establishment of Root Barriers.

Current biology : CB

Andersen TG, Molina D, Kilian J, Franke RB, Ragni L, Geldner N.
PMID: 33529644
Curr Biol. 2021 Mar 08;31(5):965-977.e5. doi: 10.1016/j.cub.2020.11.070. Epub 2021 Feb 01.

Plants deposit hydrophobic polymers, such as lignin or suberin, in their root cell walls to protect inner tissues and facilitate selective uptake of solutes. Insights into how individual root tissues contribute to polymer formation are important for elucidation of...

Cite
Andersen TG, Molina D, Kilian J, et al. Tissue-Autonomous Phenylpropanoid Production Is Essential for Establishment of Root Barriers. Curr Biol. 2021;31(5):965-977.e5doi: 10.1016/j.cub.2020.11.070.
Andersen, T. G., Molina, D., Kilian, J., Franke, R. B., Ragni, L., & Geldner, N. (2021). Tissue-Autonomous Phenylpropanoid Production Is Essential for Establishment of Root Barriers. Current biology : CB, 31(5), 965-977.e5. https://doi.org/10.1016/j.cub.2020.11.070
Andersen, Tonni Grube, et al. "Tissue-Autonomous Phenylpropanoid Production Is Essential for Establishment of Root Barriers." Current biology : CB vol. 31,5 (2021): 965-977.e5. doi: https://doi.org/10.1016/j.cub.2020.11.070
Andersen TG, Molina D, Kilian J, Franke RB, Ragni L, Geldner N. Tissue-Autonomous Phenylpropanoid Production Is Essential for Establishment of Root Barriers. Curr Biol. 2021 Mar 08;31(5):965-977.e5. doi: 10.1016/j.cub.2020.11.070. Epub 2021 Feb 01. PMID: 33529644.
Copy Download .nbib Format: NLM
The Predictive Power of Spatial Relational Reasoning Models: A New Evaluation Approach.

Frontiers in psychology

Ragni M, Brand D, Riesterer N.
PMID: 34721126
Front Psychol. 2021 Oct 13;12:626292. doi: 10.3389/fpsyg.2021.626292. eCollection 2021.

In the last few decades, cognitive theories for explaining human spatial relational reasoning have increased. Few of these theories have been implemented as computational models, however, even fewer have been compared computationally to each other. A computational model comparison...

Cite
Ragni M, Brand D, Riesterer N. The Predictive Power of Spatial Relational Reasoning Models: A New Evaluation Approach. Front Psychol. 2021;12:626292doi: 10.3389/fpsyg.2021.626292.
Ragni, M., Brand, D., & Riesterer, N. (2021). The Predictive Power of Spatial Relational Reasoning Models: A New Evaluation Approach. Frontiers in psychology, 12626292. https://doi.org/10.3389/fpsyg.2021.626292
Ragni, Marco, et al. "The Predictive Power of Spatial Relational Reasoning Models: A New Evaluation Approach." Frontiers in psychology vol. 12 (2021): 626292. doi: https://doi.org/10.3389/fpsyg.2021.626292
Ragni M, Brand D, Riesterer N. The Predictive Power of Spatial Relational Reasoning Models: A New Evaluation Approach. Front Psychol. 2021 Oct 13;12:626292. doi: 10.3389/fpsyg.2021.626292. eCollection 2021. PMID: 34721126; PMCID: PMC8550734.
Copy Download .nbib Format: NLM
[No title available]

Revista espanola de medicina nuclear e imagen molecular

Filippi L, Pelle G, Di Costanzo GG, Tortora R, Saltarelli A, Bagni O.
PMID: 33551342
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 May-Jun;40(3):181-183. doi: 10.1016/j.remn.2020.03.018. Epub 2021 Feb 05.

No abstract available.

Cite
Filippi L, Pelle G, Di Costanzo GG, et al. Ayuda de la . Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021;40(3):181-183doi: 10.1016/j.remn.2020.03.018.
Filippi, L., Pelle, G., Di Costanzo, G. G., Tortora, R., Saltarelli, A., & Bagni, O. (2021). Ayuda de la . Revista espanola de medicina nuclear e imagen molecular, 40(3), 181-183. https://doi.org/10.1016/j.remn.2020.03.018
Filippi, Luca, et al. "Ayuda de la" . Revista espanola de medicina nuclear e imagen molecular vol. 40,3 (2021): 181-183. doi: https://doi.org/10.1016/j.remn.2020.03.018
Filippi L, Pelle G, Di Costanzo GG, Tortora R, Saltarelli A, Bagni O. Ayuda de la . Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 May-Jun;40(3):181-183. doi: 10.1016/j.remn.2020.03.018. Epub 2021 Feb 05. Spanish. PMID: 33551342.
Copy Download .nbib Format: NLM
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.

Therapeutic advances in medical oncology

Rocca A, Cortesi P, Cortesi L, Gianni L, Matteucci F, Fantini L, Maestri A, Giunchi DC, Cavanna L, Ciani R, Falcini F, Bagni A, Meldoli E, Dall'Agata M, Volpi R, Andreis D, Nanni O, Curcio A, Lucchi L, Amadori D, Fedeli A.
PMID: 33613693
Ther Adv Med Oncol. 2021 Feb 09;13:1758835920985632. doi: 10.1177/1758835920985632. eCollection 2021.

BACKGROUND: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens for HER2-positive breast cancer, by exploiting the concomitant administration of trastuzumab, taxane and anthracycline, while restraining cardiac...

Cite
Rocca A, Cortesi P, Cortesi L, et al. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Ther Adv Med Oncol. 2021;13:1758835920985632doi: 10.1177/1758835920985632.
Rocca, A., Cortesi, P., Cortesi, L., Gianni, L., Matteucci, F., Fantini, L., Maestri, A., Giunchi, D. C., Cavanna, L., Ciani, R., Falcini, F., Bagni, A., Meldoli, E., Dall'Agata, M., Volpi, R., Andreis, D., Nanni, O., Curcio, A., Lucchi, L., Amadori, D., & Fedeli, A. (2021). Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Therapeutic advances in medical oncology, 131758835920985632. https://doi.org/10.1177/1758835920985632
Rocca, Andrea, et al. "Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer." Therapeutic advances in medical oncology vol. 13 (2021): 1758835920985632. doi: https://doi.org/10.1177/1758835920985632
Rocca A, Cortesi P, Cortesi L, Gianni L, Matteucci F, Fantini L, Maestri A, Giunchi DC, Cavanna L, Ciani R, Falcini F, Bagni A, Meldoli E, Dall'Agata M, Volpi R, Andreis D, Nanni O, Curcio A, Lucchi L, Amadori D, Fedeli A. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Ther Adv Med Oncol. 2021 Feb 09;13:1758835920985632. doi: 10.1177/1758835920985632. eCollection 2021. PMID: 33613693; PMCID: PMC7876584.
Copy Download .nbib Format: NLM
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.

European journal of preventive cardiology

Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP.
PMID: 33772274
Eur J Prev Cardiol. 2021 Mar 27; doi: 10.1093/eurjpc/zwab046. Epub 2021 Mar 27.

AIMS: The 12-lead electrocardiogram (ECG) is routinely performed in children with hypertrophic cardiomyopathy (HCM). An ECG risk score has been suggested as a useful tool for risk stratification, but this has not been independently validated. This aim of this...

Cite
Norrish G, Topriceanu C, Qu C, et al. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol. 2021;doi: 10.1093/eurjpc/zwab046.
Norrish, G., Topriceanu, C., Qu, C., Field, E., Walsh, H., Ziółkowska, L., Olivotto, I., Passantino, S., Favilli, S., Anastasakis, A., Vlagkouli, V., Weintraub, R., King, I., Biagini, E., Ragni, L., Prendiville, T., Duignan, S., McLeod, K., Ilina, M., Fernández, A., Bökenkamp, R., Baban, A., Drago, F., Kubuš, P., Daubeney, P. E. F., Chivers, S., Sarquella-Brugada, G., Cesar, S., Marrone, C., Medrano, C., Alvarez Garcia-Roves, R., Uzun, O., Gran, F., Castro, F. J., Gimeno, J. R., Barriales-Villa, R., Rueda, F., Adwani, S., Searle, J., Bharucha, T., Siles, A., Usano, A., Rasmussen, T. B., Jones, C. B., Kubo, T., Mogensen, J., Reinhardt, Z., Cervi, E., Elliott, P. M., Omar, R. Z., & Kaski, J. P. (2021). The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. European journal of preventive cardiology, . https://doi.org/10.1093/eurjpc/zwab046
Norrish, Gabrielle, et al. "The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy." European journal of preventive cardiology vol. (2021). doi: https://doi.org/10.1093/eurjpc/zwab046
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol. 2021 Mar 27; doi: 10.1093/eurjpc/zwab046. Epub 2021 Mar 27. PMID: 33772274.
Copy Download .nbib Format: NLM
Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes.

Vaccines

Ragni P, Marino M, Formisano D, Bisaccia E, Scaltriti S, Bedeschi E, Grilli R.
PMID: 33198368
Vaccines (Basel). 2020 Nov 12;8(4). doi: 10.3390/vaccines8040675.

We explored whether influenza vaccination (IV) affects susceptibility to SARS-CoV-2 infection and clinical outcomes in COVID-19 patients in 17,608 residents of the Italian province of Reggio Emilia undergoing a SARS-CoV-2 test. Exposure to IV was ascertained and the strength...

Cite
Ragni P, Marino M, Formisano D, et al. Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes. Vaccines (Basel). 2020;8(4)doi: 10.3390/vaccines8040675.
Ragni, P., Marino, M., Formisano, D., Bisaccia, E., Scaltriti, S., Bedeschi, E., & Grilli, R. (2020). Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes. Vaccines, 8(4), . https://doi.org/10.3390/vaccines8040675
Ragni, Pietro, et al. "Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes." Vaccines vol. 8,4 (2020). doi: https://doi.org/10.3390/vaccines8040675
Ragni P, Marino M, Formisano D, Bisaccia E, Scaltriti S, Bedeschi E, Grilli R. Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes. Vaccines (Basel). 2020 Nov 12;8(4). doi: 10.3390/vaccines8040675. PMID: 33198368; PMCID: PMC7711765.
Copy Download .nbib Format: NLM
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).

Thyroid : official journal of the American Thyroid Association

Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG.
PMID: 34541894
Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20.

No abstract available.

Cite
Forleo R, Grani G, Alfò M, et al. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021;31(12):1814-1821doi: 10.1089/thy.2021.0248.
Forleo, R., Grani, G., Alfò, M., Zilioli, V., Giubbini, R., Zatelli, M. C., Gagliardi, I., Piovesan, A., Ragni, A., Morelli, S., Puxeddu, E., Pagano, L., Deandrea, M., Ceresini, G., Torlontano, M., Puligheddu, B., Antonelli, A., Centanni, M., Fugazzola, L., Spiazzi, G., Monti, S., Rossetto, R., Monzani, F., Tallini, G., Crescenzi, A., Sparano, C., Bruno, R., Repaci, A., Tumino, D., Pezzullo, L., Lombardi, C. P., Ferraro Petrillo, U., Filetti, S., Durante, C., & Castagna, M. G. (2021). Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid : official journal of the American Thyroid Association, 31(12), 1814-1821. https://doi.org/10.1089/thy.2021.0248
Forleo, Raffaella, et al. "Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)." Thyroid : official journal of the American Thyroid Association vol. 31,12 (2021): 1814-1821. doi: https://doi.org/10.1089/thy.2021.0248
Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20. PMID: 34541894.
Copy Download .nbib Format: NLM
Measurement of the Drug Sensitivity of Single Prostate Cancer Cells.

Cancers

Abali F, Baghi N, Mout L, Broekmaat JJ, Tibbe AGJ, Terstappen LWMM.
PMID: 34885192
Cancers (Basel). 2021 Dec 02;13(23). doi: 10.3390/cancers13236083.

The treatment of cancer faces a serious challenge as cancer cells within patients are heterogeneous and frequently resistant to therapeutic drugs. Here, we introduce a technology enabling the assessment of single cancer cells exposed to different drugs. PCa cells...

Cite
Abali F, Baghi N, Mout L, et al. Measurement of the Drug Sensitivity of Single Prostate Cancer Cells. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236083.
Abali, F., Baghi, N., Mout, L., Broekmaat, J. J., Tibbe, A. G. J., & Terstappen, L. W. M. M. (2021). Measurement of the Drug Sensitivity of Single Prostate Cancer Cells. Cancers, 13(23), . https://doi.org/10.3390/cancers13236083
Abali, Fikri, et al. "Measurement of the Drug Sensitivity of Single Prostate Cancer Cells." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236083
Abali F, Baghi N, Mout L, Broekmaat JJ, Tibbe AGJ, Terstappen LWMM. Measurement of the Drug Sensitivity of Single Prostate Cancer Cells. Cancers (Basel). 2021 Dec 02;13(23). doi: 10.3390/cancers13236083. PMID: 34885192.
Copy Download .nbib Format: NLM
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.

The Lancet. Rheumatology

Fagni F, Simon D, Tascilar K, Schoenau V, Sticherling M, Neurath MF, Schett G.
PMID: 34485930
Lancet Rheumatol. 2021 Oct;3(10):e724-e736. doi: 10.1016/S2665-9913(21)00247-2. Epub 2021 Aug 27.

At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory diseases were considered to be at high risk for SARS-CoV-2 infection and the development of severe COVID-19. Data collected over the past year, however, suggest that a diagnosis...

Cite
Fagni F, Simon D, Tascilar K, et al. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses. Lancet Rheumatol. 2021;3(10):e724-e736doi: 10.1016/S2665-9913(21)00247-2.
Fagni, F., Simon, D., Tascilar, K., Schoenau, V., Sticherling, M., Neurath, M. F., & Schett, G. (2021). COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses. The Lancet. Rheumatology, 3(10), e724-e736. https://doi.org/10.1016/S2665-9913(21)00247-2
Fagni, Filippo, et al. "COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses." The Lancet. Rheumatology vol. 3,10 (2021): e724-e736. doi: https://doi.org/10.1016/S2665-9913(21)00247-2
Fagni F, Simon D, Tascilar K, Schoenau V, Sticherling M, Neurath MF, Schett G. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses. Lancet Rheumatol. 2021 Oct;3(10):e724-e736. doi: 10.1016/S2665-9913(21)00247-2. Epub 2021 Aug 27. PMID: 34485930; PMCID: PMC8397302.
Copy Download .nbib Format: NLM
Showing 313 to 324 of 324 entries